Proven impact.
Redefining the speed and standard of scientific communication.
Days
instead of months.
From source to
manuscript draft.
18x
higher engagement.
From patient &
non-specialist PLS.
250M+
publications.
Continuously ingested
and enriched.
The SciComms engine for every stage.
Sorcero SciComms™ doesn’t just summarize text. We power your entire pipeline.
Discovery
Build your strategy on a foundation of
total visibility.
Publication Intelligence
Align with evolving narratives using the industry’s largest repository of 250M+ publications.
Gap Analysis
Instantly identify evidence gaps to inform R&D priorities.
Lexicon Development
Establish core product narratives early.
Congress Materials
From complex source data to congress-ready
deliverables.
Abstracts
High-quality, SME-reviewed standards produced faster than manual drafting.
Posters
Deeply structure drafts including detailed design for figures and tables.
Oral Presentations
Rapid generation of core narratives grounded in verified source evidence.
Manuscripts
From unstructured source data to a
high-quality manuscript draft in days.
Phase I (Safety) (Coming soon)
Diverse data (Safety, PK/PD, preliminary efficacy) synthesized into coherent narratives.
Phase III (Superiority, Non-Inferiority)
Large-scale, complex datasets around primary and secondary endpoints structured in full adherence to CONSORT 2025 guidelines.
Secondary (PRO, Subgroup analyses)
Capture the patient perspective in compliance with CONSORT-PRO.
Publication Extenders
Broaden the reach of your science, helping
patients and stakeholders understand the
science behind the treatments being developed.
Plain Language Summaries (PLS)
Peer-reviewed validated PLS that meets journal requirements andstakeholder expectations.
Video PLS (vPLS)
Generate high-quality, compliant, reach-enhancing videos in a timely and cost-effective way.
Plain Language Trial Summary (PLTS)
Includes all 11 mandatory elements required by EU CTR 536/2014, Annex V.
Regulatory & Market Access
Speak the language of regulators and payors.
HEOR Narratives (coming soon)
Generate economic evidence narratives that resonate.
Regulatory Submissions
Ensure consistency across submission documents.
A new standard for scientific
content generation.
From source to delivery in less than a week.
Reduce Time-To-Publication with foundational drafts that are ethically compliant, scientifically accurate, and structurally complete.
Science for everyone.
Break down barriers to patient engagement. Transform how you create compliant PLS, exceeding FDA and EMA readability standards.
Quality you can trust.
Validated by industry leaders. We established a rigorous scoring rubric with 3 top-ten pharma companies and leading agencies.
Sorcero combines Agentic AI with mandatory Subject-Matter-Expert (SME) review to ensure unparalleled speed and scientific integrity.
Non-negotiable checks for data integrity and protocol fidelity.
Ensuring all IMRAD components and mandated elements are present.
Assessing flow, tone, and clarity.
Publication Intelligence.
Crystal clear.
Built on a better foundation.
Sorcero isn’t a generic LLM. It is the most advanced AI platform engineered specifically for Life Sciences.Industry-Leading Compliance
Engineered to meet GPP4, ICH, CONSORT, and FDA requirements.
Data Security
Full data security with a dedicated tenant for your organization.
Massive Scale
Trained on 100M+ authors and 250M+ publications.
The "Publish or Perish"
Pressure Cooker
Scientific research is exploding, but the teams responsible for communicating it are stretched thin.
![]()
Volume Overload
The pressure to publish more is relentless, but monitoring emerging trends and massive datasets is manually impossible.
![]()
The Speed Trap
Converting complex clinical data into high-quality manuscripts takes months of manual writing and review.
![]()
The Readability Gap
Despite draining time and budget, patient-facing materials often fail to meet readability standards, leaving patients and advocates in the dark.
![]()
Compliance Risk
Navigating evolving guidelines (CONSORT, STROBE, EMA CTR) is a complex, high-stakes minefield.
You don’t need a faster typewriter. You need a stronger pipeline.
Resources
Go deeper.

Read our AI validation studies published with industry partners, including UCB, Moderna, and AstraZeneca.

.png?width=300&name=Evidence%20(1).png)
Learn how the future of commercialization will be driven by superior medical intelligence.


A comprehensive guide to navigating the complexities of compliance, privacy, and trust in medical AI.

